Mobile & Wireless Technology Proven Effective for Improving Diabetes Care

ADMS Overview


GlucoMON®2 is a next generation connected device for managing blood glucose meters and facilitating automated transmission of medical device data. This device represents the fifth generation GlucoMON which not only pioneered the mHealth movement but continues to enjoy the benefits of health plan reimbursement, improved health outcomes and lower costs for providers and payors. The device is currently under development and planned for availability in 2016/17 following the completion of end user studies, ADMS certification and regulatory filings. This device is not currently being offered for sale.

Diabetech is alone in establishing the evidence base for self-care enabled by our automated diabetes management service platform. This is the result of serving more 7,000 patients over the course of more than a decade committed to the integration of advanced mobile technology and behavioral science applied to people with diabetes and conditions related to elevated blood sugar in the human body. While the technology may be similar across various forms of diabetes and wellness, the specific configuration, timing and healthy lifestyles messaging are very different depending on the participant’s profile and where they are in the management of their condition.

These programs have been extensively trialed in both self-care as well as physician directed settings. The physician directed protocols borrow from telehealth and telemedicine concepts while the non-physician directed programs focus on creating a social support network for encouragement and reinforcement while making self-care tasks easier thus encouraging behavior change. The effects from participation are carefully measured and typically result in improved outcomes such as lower average blood sugars and more time spent in the normal blood sugar range thus leading to fewer crisis encounters and lower near-term and long-term costs to the health plan.

The programs can be described as ranging from population health management at the lower end of the intensity spectrum to profile based education to screening for elevated blood sugar all the way up to high intensity programs which incorporate the world’s easiest to use automated wireless devices for real-time remote patient monitoring and diagnostic care kits are shipped to the patient’s home for collecting blood samples and episodic biometrics to facilitate quarterly assessments and more frequent feedback for improved self-care. Cost for these programs start at pennies per day. Endocrinologists are also successfully securing reimbursement for previously non-billable encounters.

These programs have already been used to modernize the care delivery model in the following areas:

  • New onset type 1 IDDM with seamless blood sugar monitoring from inpatient through discharge and continuing for 60 – 90 days of intensive monitoring and educaiton
  • Continuous Subcutaneous Insulin Infusion (CSII) (aka insulin pump) initiation for pre-pump assessment, education and follow-up monitoring for 30 days
  • Out of Control patient monitoring and intervention
  • Community based screening to detect elevated blood sugar levels in both the pre-diabetic and diabetic range in women of child-bearing age as a strategy to prevent complications including neural tube defects, premature fetal demise and premature birth due to the effects of the mother’s elevated blood sugar in the first trimester and the current gap in health care which does not typically screen for elevated blood sugar until after the first trimester when irreversible damage has already occurred.
  • Blood sugar screening and automated remote family monitoring in Independent and Assisted living communities. This program is designed to extend a senior’s independence prior to requiring skilled nursing either in home or in a nursing home facility that may be caused or exacerbated by out of control blood sugar.
  • Social network based monitoring, education and peer group support for adults with type 2 diabetes. This program was presented at the 67th Annual ADA Scientific Sessions. Using automated technology and remote diagnostics, people are now able to learn strategies for better control while also receiving just in time interventions from their own trusted support network of friends, family and co-workers.

Finally, these programs also incorporate incentives and motivational tools designed to reinforce and encourage desired self-care behaviors. Several randomized controlled clinical trials have been performed using these technologies establishing the evidence base for improved outcomes, streamlined clinical workflow and cost reduction for payors. Links to published peer-reviewed manuscripts are located here.

Health Care Provider Description

Copyright © Diabetech, LP 2009 – 2012. All rights reserved worldwide.